In humans, lung adenocarcinomas, which frequently harbor Kras mutations, often develop at the bronchio-alveolar duct junction and display either airway or alveolar differentiation, or both [38], suggesting that some of these tumors may have originated from BASC-like cells. Here, KRAS is linked to lung adenocarcinoma.